Storage and handling
Storage: Store in a cool and dry location out of direct sunlight.
Storage: Store in a cool and dry location out of direct sunlight.
Active ingredients: CAMPHOR (NATURAL) 1.42%, MENTHOL 0.8%
Inactive ingredients:
Eucalyptus globulus leaf oil, Thymol, castor oil, dodecanal, citronellol, geraniol, citronellal, cymbopogon nardus oil, benzophenone, phenoxybenzene, benzyl benzoate
Purpose:
Topical analgesic
Warnings:
For external use only.
When using this product
- use only as directed.
- do not bandage tightly or use with a heating pad.
- do not use on irritated, wounded or damaged skin.
- avoid contact with eye or mucous membranes.
Do not use if
- you are allergic to fragrance.
- you have asthma.
- you are pregnant or breast-feeding.
Stop use if
- condition worsens or symptoms persist for more than 7days.
- redness is present.
- irritation develops.
Ask a doctor if
- condition worsens or symptoms persist for more than 7days.
- redness is present.
- irritation develops.
Keep out of reach of children:
If patch is swallowed, get medical help or contact poison control center immediately.
Indication and usage:
Adults and children over 12 years
- use only as directed.
- do not use on children under 12 years of age.
- use up to 8 hours, repeat once if necessary.
- reseal pouch containing unused patches.
Storage:
Store in a cool and dry location out of direct sunlight.
Questions:
Phone: 608-362-6915
E-mail: drohpatch@gmail.com
Dosage and administration:
Use up to 8 hours, repeat once if necessary.
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1117074 | camphor 1.42 % / menthol 0.8 % Medicated Patch | PSN | 2 |
| 1117078 | Dr. Oh 1.42 % / 0.8 % Medicated Patch | PSN | 2 |
| 1117078 | camphor 0.0142 MG/MG / menthol 0.008 MG/MG Medicated Patch [Dr. Oh Patch] | SBD | 2 |
| 1117074 | camphor 0.0142 MG/MG / menthol 0.008 MG/MG Medicated Patch | SCD | 2 |
| 1117074 | camphor 1.42 % / menthol 0.8 % Medicated Patch | SY | 2 |
| 1117078 | Dr. Oh (camphor 1.42 % / menthol 0.8 % ) Medicated Patch | SY | 2 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 76163-010-01 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-d745-8e05-e053-dbdaa90a074a | Drug Facts |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 76163-010-01 | DR.OH PATCH | 2000 mg in 1 CELLO PACK | PATCH | 2000 | 2 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| CAMPHOR (NATURAL) | ACTIVE INGREDIENT | N20HL7Q941 | 2 | |
| MENTHOL | ACTIVE INGREDIENT | L7T10EIP3A | 2 | |
| CAMPHOR (NATURAL) | ACTIVE MOIETY | N20HL7Q941 | 2 | |
| MENTHOL | ACTIVE MOIETY | L7T10EIP3A | 2 | |
| .BETA.-CITRONELLOL, (R)- | INACTIVE INGREDIENT | P01OUT964K | 2 | |
| BENZOPHENONE | INACTIVE INGREDIENT | 701M4TTV9O | 2 | |
| BENZYL BENZOATE | INACTIVE INGREDIENT | N863NB338G | 2 | |
| CASTOR OIL | INACTIVE INGREDIENT | D5340Y2I9G | 2 | |
| CITRONELLA OIL | INACTIVE INGREDIENT | QYO8Q067D0 | 2 | |
| CITRONELLAL | INACTIVE INGREDIENT | QB99VZZ7GZ | 2 | |
| ETHYL ACETATE | INACTIVE INGREDIENT | 76845O8NMZ | 2 | |
| EUCALYPTUS GLOBULUS LEAF | INACTIVE INGREDIENT | S546YLW6E6 | 2 | |
| GERANIOL | INACTIVE INGREDIENT | L837108USY | 2 | |
| THYMOL | INACTIVE INGREDIENT | 3J50XA376E | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 76163-010 | 76163-010-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CAMPHOR (NATURAL) | N20HL7Q941 | ACTIB |
| MENTHOL | L7T10EIP3A | ACTIB |
| EUCALYPTUS GLOBULUS LEAF | S546YLW6E6 | IACT |
| THYMOL | 3J50XA376E | IACT |
| CASTOR OIL | D5340Y2I9G | IACT |
| .BETA.-CITRONELLOL, (R)- | P01OUT964K | IACT |
| GERANIOL | L837108USY | IACT |
| CITRONELLAL | QB99VZZ7GZ | IACT |
| CITRONELLA OIL | QYO8Q067D0 | IACT |
| BENZOPHENONE | 701M4TTV9O | IACT |
| BENZYL BENZOATE | N863NB338G | IACT |
| ETHYL ACETATE | 76845O8NMZ | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | TABLET, FILM COATED / ORAL | 15.29 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | EMULSION / OPHTHALMIC | 32 mg | ||
| ETHYL ACETATE | ETHYL ACETATE | 76845O8NMZ | FILM, EXTENDED RELEASE / TRANSDERMAL | 0.05 mg | ||
| BENZYL BENZOATE | BENZYL BENZOATE | N863NB338G | INJECTION / INTRAMUSCULAR | 1500 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | SPRAY / NASAL | NA | ||
| ETHYL ACETATE | ETHYL ACETATE | 76845O8NMZ | CAPSULE, EXTENDED RELEASE / ORAL | 382.26 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | INJECTION, SOLUTION / INTRAMUSCULAR | 525 mg | ||
| ETHYL ACETATE | ETHYL ACETATE | 76845O8NMZ | TABLET, EXTENDED RELEASE / ORAL | NA | ||
| ETHYL ACETATE | ETHYL ACETATE | 76845O8NMZ | SYSTEM / TRANSDERMAL | 41 mg | ||
| ETHYL ACETATE | ETHYL ACETATE | 76845O8NMZ | SOLUTION / ORAL | 13 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | TABLET, DELAYED RELEASE / ORAL | 0.01 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | TABLET, COATED / ORAL | 0.9 mg | ||
| ETHYL ACETATE | ETHYL ACETATE | 76845O8NMZ | SOLUTION / TOPICAL | 31 %w/w | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | GRANULE, FOR SUSPENSION / ORAL | 128 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | TABLET, EXTENDED RELEASE / ORAL | 23.27 mg | ||
| BENZYL BENZOATE | BENZYL BENZOATE | N863NB338G | INJECTION, SOLUTION / INTRAMUSCULAR | 750 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | CAPSULE / ORAL | 1.04 mg | ||
| ETHYL ACETATE | ETHYL ACETATE | 76845O8NMZ | SUSPENSION / ORAL | NA | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | SOLUTION / TOPICAL | 1.38 %w/w | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | TABLET / SUBLINGUAL | 1.6 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | GEL / NASAL | 429 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | OINTMENT / TOPICAL | 14.9 %w/w | ||
| THYMOL | THYMOL | 3J50XA376E | LIQUID / RESPIRATORY (INHALATION) | 0.01 %w/w | ||
| BENZYL BENZOATE | BENZYL BENZOATE | N863NB338G | CAPSULE / ORAL | NA | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | CAPSULE, EXTENDED RELEASE / ORAL | 47 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | INJECTION / INTRAMUSCULAR | 885 mg | ||
| THYMOL | THYMOL | 3J50XA376E | POWDER, FOR SOLUTION / ORAL | NA | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | TABLET / ORAL | 17 mg | ||
| BENZYL BENZOATE | BENZYL BENZOATE | N863NB338G | SOLUTION / INTRAMUSCULAR | 447 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 75e7420a-7f83-4fb4-b6a5-c242fecc0ba5 | 48ea81bb-e5be-481e-982f-694b5d5cb06e | 2011-08-25 | Warnings | 75e7420a-7f83-4fb4-b6a5-c242fecc0ba5 48ea81bb-e5be-481e-982f-694b5d5cb06e |
Adverse event summaries are temporarily unavailable. Other product information remains available.